The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

LONDON, England—Investigators for the REPRISE III trial testing the Lotus transcatheter valve system (Boston Scientific) have taken a closer look at two of the outlier findings that generated much of ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Researchers at Northwestern University just found a way to make a temporary pacemaker that’s controlled by light—and it’s smaller than a grain of rice. A study on the new device, published last week ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 ; Orchestra BioMed and Medtronic plc. (NYSE: MDT, Me ...

In the normal heart, the heart's lower chambers (ventricles) pump in sync with the heart's upper chambers (atria). When a person has heart failure, often the right and left ventricles do not pump ...

In the normal heart, the lower chambers (ventricles) pump at the same time and in sync with the heart's upper chambers (atria). Cardiac resynchronization therapy (CRT), also called biventricular ...

Pacemakers and defibrillators will be the topic of the day when the NorthBay Cardiac Education Series offers its quarterly presentation next week. Dominic Uchikuru, territory manager for St. Jude ...

Complete healing from pacemaker surgery can take up to 6 weeks. However, people may need to restrict themselves from certain activities, such as heavy lifting, for longer. Factors such as age and ...

NEW HOPE, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...